Agent Capital — 2022 Investments
3 investments dated 2022 · listed companies and verified rows first · show all
Zenas BioPharma is a biopharmaceutical company developing therapies for autoimmune diseases, with two late-stage drug candidates: obexelimab, a bifunctional monoclonal antibody targeting CD19 and FcγRIIb to suppress B cell activity, and orelabrutinib, an oral BTK inhibitor.
BiotechHealthtechWaltham, US
LEON O. MOULDER, JR.(Director)Lonnie Moulder(Founder, CEO & Chairman)JOSEPH FARMER(Executive Officer)HUA MU(Executive Officer, Director)
BoardPATRICK GERALD ENRIGHT(Director)inHONGBO LU(Director)
Board seatJohn Orloff· per SEC Form D
Co-investorsDelos CapitalLongitude CapitalNew Enterprise Associates (NEA)Norwest Venture PartnersQuan CapitalSR One Capital Management+1 more
Luxembourg
Joanna Shields(Director, Executive Officer)Jean Raby(Director)Olivier Brandicourt(Director)Nick Keher(Executive Officer)Susan Liautaud(Director)Ivan Griffin(Executive Officer)
Board seatJohn Orloff· per SEC Form D · filed Sep 2022
The page presents Pinco Casino, an online gambling platform offering slots, live casino, table games, and sports betting with a Turkish-language interface.
ConsumerGamingBoston, US
Board seatGeeta Vemuri· per SEC Form D
Co-investorsAstellas Venture Management LLCDC Investment PartnersSolasta VenturesUTokyo Innovation Platform Co. Ltd.Longwood Fund
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.